课题基金 / 基金详情

Modification of Cell Growth Regulation by Hepatitis C virus

Modification of Cell Growth Regulation by Hepatitis C virus
丙型肝炎病毒对细胞生长调节的修饰
批准号:
10670295
负责人:
KOHARA Kyoko
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

KOHARA Kyoko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus (HCV) infects persistently and causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma (HCC). To address the effect of persistent infection, the conditional expression system of full-genome HCV in human liver cells was established. Following HCV expression, DNA synthesis of cells was suppressed, cell growth was mainly retarded at G0/G1 phase through apoptosis independent pathway. However, after 48 days passage, cell growth has been recovered to be initial level. In order to clarify the target of HCV, we examined the expression level of growth regulators. The cell growth modification by HCV correlated to the extent of p21WAF1/CIP1 expression and hyperphosphorylation of Rb was induced after 48 days passage. This modification of p21WAF1/CIP1 by HCV was caused at transcriptional level in the p53 independent manner. Thus, HCV could modify the cell cycle checkpoint to accelerate the tomurigenicity of hepatocyte through p21WA1/CIP1.The effect of HCV in vivo was also characterized with HCV-transgenic mice model. Expression of HCV made hepatocytes more resistant to Fas-mediated apoptosis. By using in vitro and in vivo HCV expression model, we further characterized the molecular mechanism of pathogenesis of HCV.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Tanaka,T.: "Correlation of treatment response with serum anti HGV envelope(E2) protein antibody and genomic RNA." J.Med.Virol.57. 370-375 (1999)
Tanaka,T.:“治疗反应与血清抗 HGV 包膜 (E2) 蛋白抗体和基因组 RNA 的相关性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wakita, T.: "Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system"J. Biol. Chem.. 273. 9001-9006 (1998)
Wakita, T.:“Cre/loxP 系统介导的丙型肝炎病毒 cDNA 转基因小鼠中的高效条件转基因表达”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Abe A., Inoue K., Tanaka T., Kato J., kajiyama N., kawaguchiR., Tanaka S., Yoshiba and Kohara M.: "Quantitation of hepatitis B virus genomic DNA by real time detection PCR."J. Clin. Microbiology. 37. 2899-2903 (1999)
Abe A.、Inoue K.、Tanaka T.、Kato J.、kajiyama N.、kawaguchiR.、Tanaka S.、Yoshiba 和 Kohara M.:“通过实时检测 PCR 定量乙型肝炎病毒基因组 DNA”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    Impact of hepatitis C virus infection in B cells on pathogenesis
    • 批准号:
      23590547
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      KOHARA Kyoko
    • 依托单位:
    Development of the new vaccine and a delivery vector by the recombination Morbilli virus.
    • 批准号:
      14360186
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2002
    • 负责人:
      KOHARA Kyoko
    • 依托单位:
    国内基金
    海外基金
    CHS-DRG模式下ICU老年患者CRE医院感染防控对策研究
    应用Cre-loxP系统研究清热化湿法通过法尼醇X受体和HIF-1α的信号串扰抑制溃疡性结肠炎的癌转化
    • 批准号:
      2024Y9518
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      吴异兰
    • 依托单位:
    IGF2BP2协同cre调控肠道病毒A71型复制的分子机制及在减毒株构建中的应用
    基于Cre酶的靶向性de novo DNA甲基化技术和模型开发
    • 批准号:
      32300469
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      刘若尘
    • 依托单位: